CD8+ T-cells percentage in PBMCs and purity after isolation and activation. by Eiman Abdo (20642254)

Subjects:

Assessment of CD8+ T-cells viability after activation and culturing in HCM vs. NCM for 72 hours by staining with 7-AAD. by Eiman Abdo (20642254)

Subjects:

Percentages of concentration changes in TNF-α, IL-6, and IFN-γ in co-culture of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

Percentages (%) of concentration changes of cytokines for CD8+ T-cells after cultured in HCM or NCM of PANC-1 cells. by Eiman Abdo (20642254)

Subjects:

Decreased expression of Nrf2 related genes and stemness markers in Nrf2 knocked down resistant Huh7 cells treated with siRNA. by Luping Gao (4269754)

Subjects:

Supplementary Table 1 from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors by Sarah E. Fenton (15062814)

Stability of the Arginine–Ornithine–Citrulline Cycle Maintained by Tumor–Stroma Interactions in Cell Coculture Hydrogel Microspheres by Hongren Yao (8857088)

Subjects:

Overcoming the Blood–Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma by Tsung-I Hsu (3401975)

Subjects:

SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Related Article from Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells by Rolf Kiessling (149724)

Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment by Xing Fan (88299)

Subjects:

Cellular immune components of the pre-castration and post-castration within the tumor. by Nourridine Siewe (5081834)

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Figure 3 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)